
REPO4EU offers a EU-wide platform to discover new uses for existing drugs and advance precision medicine. It uses bioinformatics, AI and machine learning to analyze omics data and disease mechanisms across 28 partners. Operating as a EU-funded, B2B platform in drug repurposing, it provides a bioinformatics toolkit, a registry of academic trial sites, data resources and tools like Drugst.One and DrugRepoChatter. The platform aims to reach researchers and organizations globally, enabling mechanism-based repurposing with faster development.

REPO4EU offers a EU-wide platform to discover new uses for existing drugs and advance precision medicine. It uses bioinformatics, AI and machine learning to analyze omics data and disease mechanisms across 28 partners. Operating as a EU-funded, B2B platform in drug repurposing, it provides a bioinformatics toolkit, a registry of academic trial sites, data resources and tools like Drugst.One and DrugRepoChatter. The platform aims to reach researchers and organizations globally, enabling mechanism-based repurposing with faster development.